Zobrazeno 1 - 2
of 2
pro vyhledávání: '"P. Lief Bergsagel"'
Autor:
Joseph R. Mikhael, David Dingli, Morie A. Gertz, Angela Dispenzieri, Francis K. Buadi, Shaji Kumar, Rafael Fonseca, Betsy LaPlant, Steven R. Zeldenrust, Suzanne R. Hayman, Martha Q. Lacy, A. Keith Stewart, P. Lief Bergsagel, Stephen J. Russell, Thomas E. Witzig, John A. Lust, S. Vincent Rajkumar, Vivek Roy, Craig B. Reeder, Robert E. Hall, Kristina Laumann
Publikováno v:
Blood. 119:5397-5404
Immunoglobulin light-chain (AL) amyloidosis is a rare, incurable plasma cell disorder. Its therapy has benefited immensely from the expanding drug armamentarium available for multiple myeloma. Pomalidomide in combination with weekly dexamethasone (Po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a7ca5767db585a2964c03b4b8274d1b
https://doi.org/10.1182/blood-2012-02-413161
https://doi.org/10.1182/blood-2012-02-413161
Autor:
Angela Dispenzieri, Robert J. Dalton, Rafael Fonseca, Craig B. Reeder, S. Vincent Rajkumar, Vivek Roy, Eugene E. Keller, Steven R. Zeldenrust, Martha Q. Lacy, A. Keith Stewart, Robert A. Kyle, Philip R. Greipp, Morie A. Gertz, David Dingli, Stephen J. Russell, Shaji Kumar, Deepak Kademani, Alan B. Carr, Christopher F. Viozzi, Suzanne R. Hayman, John A. Lust, Kimberly L. Gollbach, P. Lief Bergsagel, Thomas E. Witzig
Publikováno v:
Mayo Clinic Proceedings. 81:1047-1053
Bisphosphonates are effective in the prevention and treatment of bone disease in multiple myeloma (MM). Osteonecrosis of the jaw is Increasingly recognized as a serious complication of long-term bisphosphonate therapy. Issues such as the choice of bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::616b470642bf9577a28fda0e09d8a2ab
https://doi.org/10.4065/81.8.1047
https://doi.org/10.4065/81.8.1047